Weight-loss jabs, such as Ozempic, Wegovy and Mounjaro, have quickly earned a glowing global reputation for shifting the ...

Demand for weight-loss medications ... or other medications." The study also confirmed past research findings detailing the drugs' potential to lower the risk of heart attack, stroke and other ...

They found that those taking the popular weight loss drugs, also known as glucagon-like peptide-1 receptor agonists (GLP-1RAs), had a lower risk of stroke, a heart attack, substance use disorders ...

But now there is good news for people taking weight loss medication who may be at risk. A new study indicates that the drug bimagrumab ... hospitalized from a heart attack or heart failure ...

Use of GLP-1 weight loss ... drugs for people taking them for diabetes compared with those who took other medicines. Reporting in Nature Medicine, they created an Atlas of conditions with a reduced ...

As evidence has mounted that new diabetes and weight loss drugs ... cut the risk of schizophrenia episodes and seizures. Among the other benefits observed were with reductions in heart attacks ...

GLP-1 agonists like Ozempic, Trulicity, Mounjaro, Victoza, Wegovy started as a way to treat diabetes but have since become popular for weight loss.

after results from a study showed that GLP-1 drugs cut the risk of several heart conditions, kidney diseases and brain ailments. New evidence regarding the additional benefits (besides weight loss ...

Demand for weight-loss medications ... or other medications." The study also confirmed past research findings detailing the drugs' potential to lower the risk of heart attack, stroke and other ...

Related FDA approves weight-loss drug ... risk of premature death within five years, a new Canadian study suggests. Health News // 2 days ago COVID-19 may attack arteries, increase risk to heart ...